Scarica l'app Stockscreener
11.16
5.34%
-0.63
Pre-mercato:
11.17
0.010
+0.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.79
Aprire:
$11.78
Volume 24 ore:
495.74K
Relative Volume:
0.65
Capitalizzazione di mercato:
$334.64M
Reddito:
$36.97M
Utile/perdita netta:
$-25.54M
Rapporto P/E:
-12.37
EPS:
-0.9022
Flusso di cassa netto:
$-24.45M
1 W Prestazione:
+11.49%
1M Prestazione:
+23.59%
6M Prestazione:
-59.15%
1 anno Prestazione:
-8.82%
Intervallo 1D:
$11.14
$11.78
Intervallo di 1 settimana:
$10.10
$11.82
Portata 52W:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Nome
Clearpoint Neuro Inc
Settore
Industria
Telefono
(949) 900-6833
Indirizzo
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
11.16 | 353.54M | 36.97M | -25.54M | -24.45M | -0.9022 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2023-10-24 | Iniziato | Stifel | Buy |
| 2023-02-16 | Ripresa | B. Riley Securities | Buy |
| 2022-04-05 | Ripresa | B. Riley Securities | Buy |
| 2021-03-18 | Iniziato | Lake Street | Buy |
| 2020-07-17 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
ClearPoint Neuro receives Canadian clearance for navigation system - Investing.com
ClearPoint Neuro (CLPT) Receives Medical Device License from Hea - GuruFocus
ClearPoint Neuro gets Canadian approval for navigation system - Investing.com
ClearPoint Neuro gets Canadian approval for navigation system By Investing.com - Investing.com Canada
Bigger Capital Group (CLPT) files ownership update showing 7.54% attributed to Michael Bigger - Stock Titan
Canadian regulators clear ClearPoint Neuro navigation system, expanding device reach - Traders Union
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint - ACCESS Newswire
Canada clears ClearPoint brain navigation system for clinical trial sites - Stock Titan
ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN
(CLPT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Will ClearPoint Neuro Inc benefit from current market trendsNew Guidance & Low Risk Entry Point Guides - baoquankhu1.vn
ClearPoint Neuro (NASDAQ: CLPT) seeks approval for larger equity incentive plan - Stock Titan
Whats the analyst consensus on ClearPoint Neuro Inc2026 Setups & High Accuracy Swing Trade Signals - baoquankhu1.vn
Update Report: Can ClearPoint Neuro Inc be the next market leaderQuarterly Profit Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Published on: 2026-04-08 04:16:27 - baoquankhu1.vn
ClearPoint Neuro, Inc. (CLPT) stock price, news, quote and history - Yahoo Finance UK
ClearPoint Neuro (CLPT) price target decreased by 10.71% to 25.50 - MSN
Why The ClearPoint Neuro (CLPT) Investment Story Is Shifting On Regulatory And Partnership Risks - Yahoo Finance
Value Recap: What are the future prospects of ClearPoint Neuro IncShort Setup & AI Enhanced Trading Alerts - baoquankhu1.vn
CLPT Technical Analysis & Stock Price Forecast - Intellectia AI
ClearPoint Neuro (CLPT) director awarded 755 shares as stock compensation - Stock Titan
ClearPoint Neuro (CLPT) director receives 1,270-share stock grant as fees - Stock Titan
ClearPoint Neuro (CLPT) director granted 442-share stock fee award - Stock Titan
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - msn.com
Short Interest in ClearPoint Neuro Surges 29% in March - National Today
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Up 29.0% in March - MarketBeat
Can ClearPoint Neuro Inc be the next market leaderEarnings Recap Report & Growth Focused Stock Reports - baoquankhu1.vn
What are the future prospects of ClearPoint Neuro Inc2026 Final Week & Stock Market Timing Techniques - baoquankhu1.vn
Vanguard amendment shows 0% stake in ClearPoint Neuro (CLPT) after realignment - Stock Titan
Why The ClearPoint Neuro (CLPT) Story Is Shifting After New Partner And FDA Updates - Yahoo Finance
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN
Trading Systems Reacting to (CLPT) Volatility - Stock Traders Daily
ClearPoint Neuro (CLPT) CEO exercises options and holds all shares - Stock Titan
Fundamentals Check: Will ClearPoint Neuro Inc benefit from current market trendsInsider Selling & Weekly Momentum Stock Picks - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Xtant Medical Holdings (XTNT) - The Globe and Mail
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript - Insider Monkey
Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and Synergies - TipRanks
ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses - simplywall.st
Intuitive Surgical Stock: Buy, Sell, or Hold? - AOL.com
ClearPoint Neuro Reports Record 2025 Results, Expands Growth Outlook - The Globe and Mail
ClearPoint Neuro Q4 Earnings Call Highlights - MarketBeat
Clearpoint Neuro Inc Azioni (CLPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):